PROFESSIONAL EXPERIENCE

• Vice President and Head, Nonclinical Safety & Pathobiology, Gilead Sciences, Inc. (2011-2019)
• Senior Director, Drug Safety Research & Development, Pfizer, Inc.
  • Oncology Therapeutic Area Leader (2007-2011)
  • Interim Vaccines Therapeutic Area Leader (2009)
• Research Fellow, Drug Safety Research & Development, Pfizer, Inc.
  • Development and Regulatory Strategy Lead (2006-2007)
• Associate Research Fellow, Drug Safety Research & Development, Pfizer, Inc.
  • Infectious Disease Therapeutic Area Leader (2006)
  • Site (La Jolla) Antiviral Drugs Therapeutic Area Leader (2001-2005)
• Senior Toxicology Specialist and Leader, HERA-Americas Health Group, Environment, Health, and Safety (EHS) Department, Dow Corning Corporation (now, The Dow Chemical Company), Midland, MI (2000-2001)
• Toxicology Specialist/Senior Toxicology Specialist, Americas Product Toxicology, Health, Environmental, and Regulatory Affairs (HERA) Group, EHS Department, Dow Corning Corporation, Midland, MI (1997-2000)
• Toxicology Specialist and Supervisor, Immunotoxicology, Toxicology Laboratory, Health and Environmental Sciences Department, Dow Corning Corporation, Midland, MI (1994-1996)

EDUCATION AND CERTIFICATIONS

• European Registered Toxicologist, UK Register (since 2012)
• Fellow, Academy of Toxicological Sciences (since 2010)
• Diplomate, American Board of Toxicology (since 1997)
• Postdoctoral Fellow, Signal Transduction/T Cell Activation, Department of Immunology, Mayo Clinic & Foundation, Rochester, MN
• Ph.D.  Pharmacology and Toxicology (focus: immunotoxicology), Medical College of Virginia, Richmond, VA